What Happened
A federal court in the Middle District of North Carolina entered a consent decree in July 2022 against Asheboro Drug Company of Asheboro and its pharmacists Isaac F. Brady III and Isaac F. Brady IV, resolving a complaint filed July 7. The complaint alleged they dispensed prescription opioids while disregarding red flags of abuse and diversion, such as dangerous drug combinations, long-term high-dose opioid fills and early refills. The defendants agreed to pay $300,000 in civil penalties and to an injunction restricting the filling of certain red-flag prescriptions.
“agreed to pay the $300,000 civil monetary penalty and be bound by the consent decree of injunction”
Related Guidance
- 15 Red Flags of Drug Diversion — Behavioral and transactional indicators of diversion.
- Investigation Playbook — How to investigate suspected diversion inside an organization.